01 8BOEHRINGER INGELHEIM
01 88551957
01 8Blank
01 6Y
02 2Blank
01 82029-10-14
Patent Expiration Date : 2029-10-14
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2730
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2029-10-14
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2730
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim :
Application Number : 204629
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2029-10-14
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2730
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2029-10-14
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 206073
Patent Use Code : U-1651
Delist Requested :
Patent Use Description : METHOD OF TREATING TYP...
Patent Expiration Date : 2029-10-14
Patent Expiration Date : 2029-10-14
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8551957
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 212614
Patent Use Code : U-2730
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-10-14
